Sunday, August 3, 2014

No treatment or vaccine against Ebola

Extremely low risk

This is the first time a person infected with Ebola virus is on American soil, but American authorities say they are confident and able to protect the public from the risk of transmission. "Doctors, nurses and staff of the University Hospital Emory can treat both patients safely and effectively. We are honored to have the privilege of treating these patients who contracted Ebola participating in a mission humanitarian, "said the hospital in a statement.

It stated that Dr. Brantly and Nancy are the only two Writebol patients treated at their institution, "not because of the risk of contamination, but rather for reasons of protection of privacy, given the widespread interest in these patients, "he said hospital.

Ebola is a virulent pathogen that causes a mortality of 60-90% of patients. It is transmitted through direct contact with body fluids such as blood or sweat of patients with symptoms. "The risk (of contamination, Ed) is extremely low, because even if someone is infected in the United States or other developed countries, it is highly unlikely that the virus can spread the light of hospital capacity to isolate these patients, "said Dr. Anthony Fauci, director of the American Institute of Allergy and Infectious Diseases (NIAID).

No treatment or vaccine against Ebola

Emory University Hospital, which is also located near the federal Centers for Disease Control and Prevention (CDC), has "a special unit to put in quarantine sick" when they have certain dangerous infectious diseases, one of four such units existing in the United States.

Dr. Tom Frieden, director of the CDC, has reminded his side there is currently no treatment or vaccine against Ebola, a virus identified in 1976.

But "with meticulous work to find the sick, people with whom they were in contact, the chain of transmission of the virus will be stopped," he had ruled Friday, saying it will in the best case at least three to six months to overcome the current epidemic.

No comments:

Post a Comment